Bayer has completed the acquisition of the consumer care business of US pharma group Merck & Co.
“This acquisition is a milestone for Bayer and we intend to continue the expansion of our attractive over-the-counter business both through organic growth and bolt-on acquisitions,” explained Bayer CEO Dr. Marijn Dekkers. Bayer paid a purchase price of USD 14.2 billion for the business, which has reportedly already begun a course of integration into the German giant’s operations.
The combined consumer care business is headed by Erica Mann, member of the Bayer HealthCare Executive Committee and responsible for the Consumer Care division.